Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054. Issue 1 (18th January 2022) - Eggermont, Alexander; Kicinski, Michal; Suciu, Stefan